blood pressure and established hypertension 1) . The report demonstrated that subjects with systolic blood pressure (SBP) between 120 and 139 mmHg or diastolic blood pressure (DBP) 80 and 89 mmHg were categorized as having prehypertension 1) . Prehypertension frequently progresses to clinical hypertension over several years, especially in older adults 2) . For SBP and DBP, the incremental relationship between blood pressure and cardiovascular disease (CVD) risk is continuous, independent of other risk factors, predictive, consistent, and generally assessed as etiologically significant [3] [4] [5] . Prehypertension as well as hypertension is associated with an increased risk of major CVD events,
Introduction
In 2003, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure proposed a new classification for individuals between normal thus lifestyle modification or even medical treatment is recommended for individuals with prehypertension 1) . Metabolic syndrome is prevalent in the hypertensive stage in the Japanese population 6, 7) and insulin resistance relates to the underlying mechanisms of these abnormalities 6) ; however, little is known about insulin resistance in subjects with prehypertension. The aim of this study was to assess whether insulin resistance was associated with a risk for prehypertension as well as hypertension; we examined cross-sectional data from community-dwelling participants.
Materials and Methods

Subjects
Participants were recruited at the time of their annual health examination in a rural town, Nomuracho, Seiyo-city, which has total population of 11,136 (as of April 2002) and is located in Ehime prefecture, Japan, in 2002. Among 9,133 adults aged 19 to 90 years in this population, 3,164 (34.6%) were recruited at the community-based annual medical check-up and agreed to join the study. Information on medical history, present conditions, and drug usage was obtained by interview. Other characteristics, such as smoking and alcohol drinking, were investigated by individual interviews using a structured questionnaire. Daily alcohol consumption was measured using the Japanese liquor unit in which 1 unit corresponds to 22.9 g ethanol. Subjects taking medications for hypertension, diabetes, or dyslipidemia and with a clinical history of stroke, transient ischemic attack, myocardial infarction, or angina were excluded. The final study sample included 1,269 eligible persons. This study was approved by the ethics committee of Ehime University School of Medicine, and written informed consent was obtained from each subject.
Evaluation of Risk Factors
Information on demographic characteristics and risk factors was collected from the clinical records. Body mass index was calculated by dividing weight (in kilograms) by the square of the height (in meters). We measured blood pressure once in the right upper arm of participants in a sedentary position using an automatic oscillometric blood pressure recorder (BP-103i; Colin, Aichi, Japan) while they were seated after having rested for at least 5 min. Appropriate cuff bladder size was determined at each visit based on arm circumference. Normotension was defined as not being on antihypertensive medication and having a SBP of 120 mmHg and DBP of 80 mmHg. Prehypertension was defined as not being on antihypertensive medication and having a SBP of 120 to 139 mmHg and/or DBP of 80 to 89 mmHg. Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg 1) . Cigarette smoking was quantified based on daily consumption and history of smoking, and drinking status (never, sometimes, daily). Total cholesterol (T-C), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), fasting blood glucose (FBG), creatinine (enzymatic method), uric acid, and immunoreactive insulin (IRI) were measured during fasting. Low-density lipoprotein cholesterol (LDL-C) level was calculated by the Friedewald formula. Participants with TG levels ≥ 400 mg/dL were excluded (25 cases Homeostasis of minimal assessment of insulin resistance (HOMA-IR) was calculated from FBG and IRI levels using the following formula; FBG {(mg/dL) X IRI (mU/mL)}/405 8) , and a borderline level of insulin resistance was defined as HOMA-IR ≥ 1.6 8) , and a definite level, HOMA-IR ≥ 2.5 9) .
Metabolic Syndrome
We applied condition-specific cutoff points for MetS based on the modified guidelines for the diagnosis of MetS in Japan 9) . Metabolic syndrome was defined as obesity with at least two of the following three conditions: hypertension, dyslipidemia, and impaired fasting glucose (IFG). Obesity was defined as BMI ≥ 25.0 kg/m 2 10, 11) . Hypertension was defined as systolic blood pressure (SBP) ≥ 130 mmHg, diastolic blood pressure (DBP) ≥ 85 mmHg. Dyslipidemia was defined as TG concentrations ≥ 150 mg/dL and low HDL cholesterol (HDL-C 40 mg/dL). Impaired fasting glucose was defined as a FBG level ≥ 110 mg/dL. Metabolic risk score was calculated as the number of components of MetS that clustered in the same subjects.
Statistical Analysis
Statistical analyses were performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). All values are expressed as the mean standard deviation (SD), unless otherwise specified. Data for smoking status, TG, FBG, IRI and HOMA-IR were skewed, and were log-transformed for multivariate analysis. Differences among groups were analyzed by the Mann-Whitney U test or chisquare ( 2 ) test. Correlations between various characteristics and log HOMA-IR were determined using Spearman's correlation. Logistic regression analyses were used to test significant factors of prehypertension (versus normotension) and hypertension status (versus normotension), with prehypertension and hypertension serving as the dichotomous outcome variables. A value of p 0.05 was considered significant.
Results
The subjects comprised 567 men aged 57 14 (mean standard deviation; range, 20 − 84) years and 702 women aged 59 12 (21 − 88) years. Table 1 shows the characteristics of the study participants with and without metabolic syndrome. The number of male participants with MetS was significantly higher than without. Also, participants with MetS had significantly higher values for BMI, smoking status, SBP, DBP, TG, LDL-C, FBG, IRI, serum creatinine, and serum uric acid. Age and HDL-C levels were significantly lower in participants with MetS. There were no inter-group differences in drinking status, T-C, LDL-C and eGFR. Overall, 25.1%, 56.4%, 15.7%, 5.1% and 11.7% of the study sample had obesity, hypertension, hypertriglyceridemia, low HDL-cholesterol, and impaired fasting glucose, respectively. Table 2 shows the characteristics of the three categories of blood pressure. Subjects with hypertension represented the highest percentage of the sample. The highest prevalence of MetS was found among hypertension subjects (13.0%), followed by prehypertension subjects (11.1%). The metabolic score increased significantly in the three categories of blood pressure. Subjects with prehypertension showed intermediate levels of age, BMI, smoking status, daily drinking status, T-C, TG, LDL-C, FBG, IRI, and HOMA-R, and these values significantly increased in parallel to blood pressure. Of note is that HDL-C was significantly lower in prehypertension as compared with the other groups, as normotension and hypertension had similar mean values. Subjects with normotension had slightly lower mean creatinine and uric acid values, and higher eGFR.
The HOMA-IR significantly correlated with systolic (r 0.171) and diastolic blood pressure (r 0.170) (Fig. 1) . The presence of hypertriglycerides, MetS, serum uric acid ≥ 7.0 mg/dL, HDL-C 40 mg/dL, and HOMA-IR ≥ 2.5 showed the highest crude OR for progression from normotension to prehypertension, and age ≥ 65 years, HOMA-IR ≥ 2.5, FBG ≥ 110 mg/dL, and MetS showed the highest crude OR for progression from normotension to hypertension, as shown in Table 3 . After adjustments for age (≥ 65 years), gender, smoking status (≥ 20 pack years), daily drinking status, and serum uric acid (≥ 7.0 mg/dL), multivariate logistic regression analysis showed that TG ≥ 150 mg/dL, HOMA-IR ≥ 2.5, MetS, HDL-C 40 mg/dL, HOMA-IR ≥ 1.6, and BMI ≥ 25 kg/m 2 were independently associated with prehypertension, and HOMA-IR ≥ 2.5, MetS, BMI ≥ 25 kg/m 2 , HOMA-IR ≥ 1.6, FBG ≥ 110 mg/dL, and TG ≥ 150 mg/dL were associated with the presence of hypertension ( Table 4) . In addiction, when we analyzed the data by sex, HOMA-IR ≥ 2.5 was also significantly associated with prehypertension or hypertension in both genders ( Table 5) .
Discussion
In this cross-sectional, population-based study, we determined the prevalence of prehypertension and hypertension, as defined by JNC-7 criteria (Chobanian 2003) , and their relationship to serum insulin, HOMA-IR levels, and MetS. This study showed that prehypertension and hypertension are extremely common, affecting more than 30% of subjects (34.1% and 38.8, respectively), and both SBP and DBP significantly increased with increasing HOMA-IR levels. Furthermore, higher HOMA-IR levels and MetS were significantly associated with the risk for prehypertension or hypertension, even after adjusting for age, gender, smoking status, drinking status, and uric acid. We further suggest that HOMA-IR levels are related to clinical prehypertension, a disease state where primary prevention is possible.
The prevalence of prehypertension and hypertension has been increasing in Japan 12) , and the high prevalence of both conditions in the current study was similar to that reported from the US, China, and Korea. Elevated blood pressure is a serious problem in the United States, and approximately 60% of American adults have prehypertension or hypertension 13) In Northeast China, the prevalence of prehypertension and hypertension in Mongolian people is 43.6% and 42%, respectively, and for Han people is 44.3% and 36.7%, respectively 14) . In the Korean population, the estimated age-adjusted prevalence of hypertension and prehypertension was 22.9% and 31.6%, respectively 15) . The prevalence of prehypertension and hypertension is very high in Asian as well as US adults, and they are associated with many risk factors. In our study, 10.0% of participants had MetS, and those with prehypertension or hypertension had more notable MetS than those with normotension (12.8% and 9.2%, respectively); however, the global prevalence of MetS in our population was lower than in other studies 7, 16, 17) . It was difficult to compare our study with other studies because the response rate was low and standardized methods differed among studies. In addition, in the current study, subjects with a clinical history of CVD and taking medications for hypertension, diabetes, or dyslipidemia were excluded, and participants were strictly restricted to communitydwelling persons without overt daily-life-limiting diseases, although the prevalence of classical CVD risk factors was similar to other studies 7, 18) . Our most important findings are not the absolute prevalence of MetS but rather the differences in background characteristics among the three categories of blood pressure; therefore, we believe that our findings are highly representative. Indeed, MetS, its components, and HOMA-IR were significantly associated with both prehypertension and hypertension.
In our previous study, increasing BMI categories were positively associated with prehypertension and hypertension 12) . Similar results were found in a community-based, cross-sectional study in Taiwanese 19) . Obesity has been proposed as an etiology of insulin resistance, and hypertensive patients with insulin resistance were more obese than those with out insulinresistance 20) . The triad of obesity, hypertriglyceridemia, and low HDL-C has been identified as a surrogate maker of insulin resistance 21) . In the current study, the metabolic risk score and prevalence of MetS increased significantly in subjects with prehypertension or hypertension. In subjects with prehypertension to hypertension, age, BMI, smoking status, daily drinking status, T-C, TG, LDL-C, FBG, IRI, and HOMA-IR were significantly increased in parallel to Homeostasis of minimal assessment of insulin resistance (HOMA-IR) was calculated from fasting blood glucose (FBG) and immunoreactive insulin (IRI) levels using the following formula; FBG (mg/dL) X IRI (mU/mL)/405. Adjusted for age (≥ 65 years), smoking status (≥ 20 pack per year), daily drinking status, and serum uric acid (≥ 7.0 mg/dL). blood pressure, while eGFR decreased. HOMA-IR has been reported to be significantly and independently higher in prehypertension and hypertension than in normotension 22, 23) . Our results also demonstrated that the cluster of these risk factors with insulin resistance increases the possibility of presenting with prehypertension and hypertension.
The mechanisms that lead to prehypertension in individuals with insulin resistance are not completely understood. Several previous studies showed that insulin resistance is correlated with an important underlying status of MetS 6) and increased risk factors of cardiovascular disease 24) . Obesity per se induces insulin resistance and plays a central role in the regulation of MetS 25) . Moreover, overweight, impaired fasting glucose, hypertriglyceridemia, and low HDL-C are surrogate makers of insulin resistance and, in our study, were regarded as strong risk factors for both prehypertension and hypertension. In particular, our result demonstrated that the cluster of these two risk factors with a BMI ≥ 25 kg/m 2 increases the possibility of presenting with prehypertension. Background mechanisms include activation of the sympathoadrenal system 26) , the adipose renin-angiotensin-aldosterone system 27) , increased systemic oxidative stress, diminished concentration of nitric oxide derivatives and antioxidant vitamins, endothelial oxidative damages 28) , and excess intravascular volume caused by sodium reabsorption 29) . All these factors result in atherosclerosis, and prehypertension may be complicated by both the severity and duration of atherosclerosis, and vice versa. In the current study, the prevalence of prehypertension and hypertension was significantly higher in men than women, and similar results have been shown in different ethnic groups 15, 30) . Furthermore, we also found an increased risk of prehypertension and hypertension among men with insulin resistance or MetS compared with women. As men have more visceral and hepatic adipose tissue, and women have a possible protective effect of estrogen, the effect of insulin resistance might be stronger in men than women 31) . Some limitations of this study must be considered. First, the response rate was as low as 35%, which is observed mostly in other conventional community studies in Japan. However, the relatively large sample size enabled assessment of an extensive array of insulin resistance in relation to prehypertension and hypertension. Second, the cross-sectional study design is limited in its ability to eliminate causal relationships between prehypertension and HOMA-IR. Third, the prevalence of various BP categories is based on a single assessment of blood pressure, which may introduce a misclassification bias. Fourth, we used BMI ≥ 25 kg/m 2 to classify individuals with obesity, because waist circumference measurements were not available. This might have caused an underestimation of the effect of visceral obesity on MetS 32) ; therefore, the demographics and referral source may limit generalizability.
In conclusion, this study showed that BMI ≥ 25 kg/m 2 , TG ≥ 150 mg/dL, presence of MetS, HOMA-IR ≥ 1.6, or HOMA-IR ≥ 2.5 were significantly associated with elevated blood pressure in the general population. The underlying mechanism behind this relationship is insulin resistance, and seems to be independent of traditional confounding factors, such as age, gender, smoking status, drinking status, and serum uric acid. Further investigation of longitudinal data from our study will provide more definitive answers to this issue.
